{{Rsnum
|rsid=10255878
|Chromosome=7
|position=97388483
|Orientation=plus
|GMAF=0.2296
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 25.9 | 74.1
| HCB | 10.2 | 37.2 | 52.6
| JPT | 8.9 | 46.4 | 44.6
| YRI | 8.2 | 42.5 | 49.3
| ASW | 8.8 | 40.4 | 50.9
| CHB | 10.2 | 37.2 | 52.6
| CHD | 11.0 | 29.4 | 59.6
| GIH | 5.0 | 31.7 | 63.4
| LWK | 21.8 | 52.7 | 25.5
| MEX | 0.0 | 17.5 | 82.5
| MKK | 11.8 | 51.6 | 36.6
| TSI | 2.0 | 20.6 | 77.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23719583
  |Trait=Adverse response to radiation therapy
  |Title=Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.
  |RiskAllele=
  |Pval=4E-6
  |OR=5.20
  |ORtxt=[1.9-14.5]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}